The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Differences in cancer incidence by broad ethnic group in England, 2013–2017
Open accessAbstract
Background: Cancer incidence variation between population groups can inform public health and cancer services. Previous studies have shown cancer incidence rates vary by ethnic group in England. Since their publication, the completeness of ethnicity recording in cancer data has improved, and relevant inequalities (e.g. risk factor prevalence and healthcare access) may have changed. Methods: Age-standardised incidence rates were calculated for Asian, Black, Mixed/Multiple and White ethnic groups in England in 2013–2017, using almost 3 million diagnoses across 31 cancer sites. Rate ratios were calculated with the White ethnic group as reference. Sensitivity analyses used imputed ethnicity for cases with missing data and perturbed population estimates. Results: Incidence rates for most cancer sites and ethnic group and sex combinations were lower in non-White minority ethnic groups compared with the corresponding White group, with particularly low rate ratios (below 0.5) for melanoma skin cancer and some smoking-related cancers (lung, bladder and oesophageal cancers). Exceptions included prostate cancer (2.1 times higher in males of Black ethnicity), myeloma (2.7–3.0 times higher in people of Black ethnicity), several gastrointestinal cancers (1.1–1.9 times higher in people of Black ethnicity, 1.4–2.2 times higher in people of Asian ethnicity), Hodgkin lymphoma (1.1 times higher in males of Asian ethnicity, 1.3 times higher in males of Black ethnicity) and thyroid cancers (1.4 times higher in people of Asian ethnicity, 1.2 times higher in people of Black ethnicity). Sensitivity analyses did not materially alter these results (rate ratios changed by a maximum of 12 percentage points, the direction and significance of results were unchanged in all but two cancer site/sex/ethnic group combinations). Conclusions: People of non-White minority ethnicity in England generally have lower cancer risk than the White population, though there are a number of notable exceptions. These results should galvanise efforts to better understand the reasons for this variation, and the possible impact on cancer services, patient experiences and outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In some diseases, such as cancer, incidence and mortality rates tend to be lower among White ethnic groups in the UK compared to other groups.
“Yet, multiple sources indicate that in some diseases, such as cancer, the incidence and mortality rates tend to be lower among White ethnic groups in the UK compared to other groups [21–23].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [22]
The Discussion (Summary of results; page unavailable) reports the opposite general pattern: cancer incidence was lower in non-White minority groups than in the White group, with exceptions including Black males. The paper examines incidence, not mortality, so it does not establish the mortality comparison. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
Hooi, J. K. Y., Lai, W. Y., Ng, W. K., Suen, M. M. Y., Underwood, F. E., Tanyingoh, D., Malfertheiner, P., Graham, D. Y., Wong, V. W., Wu, J. C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.022 · Cited by 3,391
International Agency for Research on Cancer (IARC)
(2018) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-94186-5_629 · Cited by 2,796
Turra, C. M., & Elo, I. T. (2008) · Population Research and Policy Review · doi:10.1007/s11113-008-9087-4 · Cited by 385
Cultural Issues in Medication Adherence: Disparities and Directions
McQuaid, E. L., & Landier, W. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4199-3 · Cited by 326
Cancer risk diversity in non-western migrants to Europe: An overview of the literature
Arnold, M., Razum, O., & Coebergh, J. W. W. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.050 · Cited by 196
The effectiveness of NHS smoking cessation services: a systematic review
Bauld, L., Bell, K., McCullough, L. B., Richardson, L., & Greaves, L. (2009) · Journal of Public Health · doi:10.1093/pubmed/fdp074 · Cited by 184
Nierkens, V., Hartman, M. A., Nicolaou, M., Vissenberg, C., Beune, E., Hosper, K., van Valkengoed, I. G. M., & Stronks, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073373 · Cited by 176
Rapid review of evaluation of interventions to improve participation in cancer screening services
Duffy, S. W., Myles, J. P., Maroni, R., & Mohammad, A. (2016) · Journal of Medical Screening · doi:10.1177/0969141316664757 · Cited by 165
Szczepura, A. K., Price, C., & Gumber, A. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-346 · Cited by 158
Saunders, C. L., Abel, G., Turabi, A. E., Ahmed, F., & Lyratzopoulos, G. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002882 · Cited by 134
Moore, S., Antoni, S., Colquhoun, A., Healy, B. A., Ellison‐Loschmann, L., Potter, J. D., Garvey, G., & Bray, F. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00232-6 · Cited by 133
Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England
Jack, R. H., Davies, E., & Møller, H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604852 · Cited by 129
The fertility of ethnic minorities in the UK, 1960s–2006
Coleman, D. A., & Dubuc, S. (2010) · Population Studies · doi:10.1080/00324720903391201 · Cited by 127
Pinder, R. J., Ferguson, J., & Møller, H. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011938 · Cited by 96
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis
Harris, R., Ramsay, M. E., Hope, V. D., Brant, L. J., Hickman, M., Foster, G. R., & Angelis, D. D. (2011) · European Journal of Public Health · doi:10.1093/eurpub/ckr083 · Cited by 88
Barron, E., Clark, R., Hewings, R., Smith, J. A. E., & Valabhji, J. (2017) · Diabetic Medicine · doi:10.1111/dme.13562 · Cited by 85
Collaborators, O. B. O. T. M. W. S., Gathani, T., Ali, R., Balkwill, A., Green, J., REEVES, G. K., Beral, V., & Moser, K. A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.632 · Cited by 81
Migration and Health in England and Scotland: a Study of Migrant Selectivity and Salmon Bias
Wallace, M., & Kulu, H. (2013) · Population Space and Place · doi:10.1002/psp.1804 · Cited by 74
Ethnic differences in cancer symptom awareness and barriers to seeking medical help in England
Nikšić, M., Rachet, B., Warburton, F. G., & Forbes, L. J. L. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.158 · Cited by 74
Smith, N. R., Kelly, Y. J., & Nazroo, J. Y. (2011) · European Journal of Public Health · doi:10.1093/eurpub/ckr070 · Cited by 73
Inherited genetic predisposition in breast cancer
Rebbeck, T. R. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11+ · Cited by 73
Jack, R. H., Møller, H., Robson, T., & Davies, E. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005586 · Cited by 73
Lung cancer in never smokers in the UK Million Women Study
Pirie, K. L., Peto, R., Green, J., REEVES, G. K., Beral, V., & Collaborators, F. T. M. W. S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30084 · Cited by 70
Ethnic disparities in knowledge of cancer screening programmes in the UK
Robb, K. A., Wardle, J., Stubbings, S., Ramirez, A. J., Austoker, J., Macleod, U., Hiom, S., & Waller, J. (2010) · Journal of Medical Screening · doi:10.1258/jms.2010.009112 · Cited by 64
Incidence of haematological malignancies by ethnic group in E ngland, 2001–7
Shirley, M. H., Sayeed, S., Barnes, I. M., Finlayson, A. E. T., & Ali, R. (2013) · British Journal of Haematology · doi:10.1111/bjh.12562 · Cited by 51
Ethnicity estimation using family naming practices
Kandt, J., & Longley, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201774 · Cited by 51
Ethnic inequalities in time to diagnosis of cancer: a systematic review
Martins, T., Hamilton, W. T., & Ukoumunne, O. C. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-197 · Cited by 50
Campbell, C., Douglas, A., Williams, L. J., Cezard, G. I., Brewster, D., Buchanan, D., Robb, K. A., Stanners, G., Weller, D., Steele, R. J., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037011 · Cited by 50
Bhopal, R. S., Bansal, N., Steiner, M. F. C., Brewster, D., & Study, O. B. O. T. S. H. A. E. L. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001957 · Cited by 46
Godden, S., Ambler, G., & Pollock, A. M. (2010) · Journal of Medical Ethics · doi:10.1136/jme.2009.033845 · Cited by 46
Møller, H., Henson, K. E., Lüchtenborg, M., Broggio, J., Charman, J., Coupland, V. H., Davies, E., Jack, R. H., Sullivan, R. J., Vedsted, P., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.335 · Cited by 46
Massat, N. J., Douglas, E., Waller, J., Wardle, J., & Duffy, S. W. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007735 · Cited by 43
Askari, A., Nachiappan, S., Currie, A., Bottle, A., Abercrombie, J. F., Athanasiou, T., & Faiz, O. D. (2017) · International Journal of Surgery · doi:10.1016/j.ijsu.2017.04.050 · Cited by 41
Willoughby, B. J., Faulkner, K., Stamp, E., & Whitaker, C. J. (2006) · Journal of Public Health · doi:10.1093/pubmed/fdl062 · Cited by 40
Incidence of gastrointestinal cancers by ethnic group in England, 2001–2007
Ali, R., Barnes, I. M., Cairns, B. J., Finlayson, A. E. T., Bhala, N. B., Mallath, M. K., & Beral, V. (2012) · Gut · doi:10.1136/gutjnl-2012-303000 · Cited by 38
Maringe, C., Mangtani, P., Rachet, B., Leon, D. A., Coleman, M. P., & dos‐Santos‐Silva, I. (2012) · International Journal of Cancer · doi:10.1002/ijc.27826 · Cited by 37
Karlsen, S., Millward, D., & Sandford, A. (2011) · European Journal of Public Health · doi:10.1093/eurpub/ckr097 · Cited by 33
Shirley, M. H., Barnes, I. M., Sayeed, S., Finlayson, A. E. T., & Ali, R. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-979 · Cited by 31
Jack, R. H., Davies, E., & Møller, H. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08940.x · Cited by 30
Ethnicity in relation to incidence of oesophageal and gastric cancer in England
Coupland, V. H., Lagergren, J., Konfortion, J., Allum, W., Mendall, M. A., Hardwick, R. H., Linklater, K. M., Møller, H., & Jack, R. H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.465 · Cited by 29
Aspinall, P. J., & Mitton, L. (2014) · Public Health · doi:10.1016/j.puhe.2013.12.013 · Cited by 28
Incidence of thyroid cancer in England by ethnic group, 2001–2007
Finlayson, A. E. T., Barnes, I. M., Sayeed, S., McIver, B., Beral, V., & Ali, R. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.4 · Cited by 26
Maile, E. J., Barnes, I. M., Finlayson, A. E. T., Sayeed, S., & Ali, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154347 · Cited by 26
Lung cancer incidence and survival in different ethnic groups in South East England
Jack, R. H., Davies, E., & Møller, H. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.282 · Cited by 24
Smith, L., Norman, P. D., Kapetanstrataki, M., Fleming, S., Fraser, L., Parslow, R. C., & Feltbower, R. G. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016332 · Cited by 21
Maruthappu, M., Barnes, I. M., Sayeed, S., & Ali, R. (2015) · BMC Cancer · doi:10.1186/s12885-015-1771-2 · Cited by 19
Taylor, C., Bhavnani, V., Zasada, M., USSHER, M. H., & Bick, D. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034747 · Cited by 19
Breast cancer and age in Black and White women in South East England
Jack, R. H., Davies, E., & Møller, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.26088 · Cited by 17
Sayeed, S., Barnes, I. M., & Ali, R. (2017) · BMC Cancer · doi:10.1186/s12885-017-3551-7 · Cited by 16
Primary liver cancer incidence and survival in ethnic groups in England, 2001–2007
Jack, R. H., Konfortion, J., Coupland, V. H., Kocher, H. M., Berry, D. P., Allum, W., Linklater, K. M., & Møller, H. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.10.008 · Cited by 11
Abbott, S., Parretti, H. M., Hazlehurst, J., & Tahrani, A. A. (2020) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12850 · Cited by 10
Chambers, A., Dixon, S., White, P., Thomas, M. G., Williams, A. C., & Messenger, D. E. (2020) · Colorectal Disease · doi:10.1111/codi.15361 · Cited by 9
Names-based ethnicity enhancement of hospital admissions in England, 1999–2013
Petersen, J., Kandt, J., & Longley, P. (2021) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2021.104437 · Cited by 7
Wu, A. H., Vigen, C. L. P., Butler, L. M., & Tseng, C. (2017) · International Journal of Cancer · doi:10.1002/ijc.31018 · Cited by 5
Flagged first, then by citations
Cited by
Sorted by citations
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
Jubber, I., Ong, S., Bukavina, L., Black, P. C., Compérat, É., Kamat, A. M., Kiemeney, L. A. L. M., Lawrentschuk, N., Lerner, S. P., Meeks, J. J., et al. (2023) · European Urology · doi:10.1016/j.eururo.2023.03.029 · Cited by 549
Barlow, M., Down, L., Mounce, L. T. A., Merriel, S. W., Watson, J., Martins, T., & Bailey, S. E. R. (2022) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-022-00613-7 · Cited by 58
Surgical health policy 2025–35: strengthening essential services for tomorrow's needs
Nepogodiev, D., Picciochi, M., Ademuyiwa, A. O., Adisa, A., Agbeko, A. E., Aguilera, M. L., Agyei, F., Alexander, P. V., Henry, J. C. A., Anyomih, T. T. K., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00985-7 · Cited by 62
Kalsi, D., Thomas, L., Hyde, C., Dan, M., Greenhalgh, J., & Ko, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1264846 · Cited by 53
Moss, E. L., Taylor, A., Andreou, A., Ang, C., Arora, R., Attygalle, A. D., Banerjee, S. N., Bowen, R. L., Buckley, L., Burbos, N., et al. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.06.025 · Cited by 49
Down, L., Barlow, M., Bailey, S. E. R., Mounce, L. T. A., Merriel, S. W., Watson, J., & Martins, T. (2024) · BMC Medicine · doi:10.1186/s12916-024-03283-5 · Cited by 42
Alarcón Garavito, G. A., Gilchrist, K., Ciurtin, C., Khanna, S., Chambers, P., McNally, N., Merivale, E., Carr, E., Yu, R., & Vindrola-Padros, C. (2025) · Trials · doi:10.1186/s13063-025-08769-y · Cited by 42
Marsden, H., Kemos, P., Venzi, M., Noy, M., Maheswaran, S., Francis, N., Hyde, C., Mullarkey, D., Kalsi, D., & Thomas, L. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1302363 · Cited by 39
Rashid, T., Bennett, J. E., Muller, D. C., Cross, A. J., Pearson‐Stuttard, J., Asaria, P., Daby, H. I., Fecht, D., Davies, B., & Ezzati, M. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00530-2 · Cited by 35
Allen, I., Hassan, H., Joko-Fru, W. Y., Huntley, C., Loong, L., Rahman, T., Torr, B., Bacon, A., Knott, C. S., José, S., et al. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100903 · Cited by 27
Self-citationPetitjean, C., Wilcox, N., Ficorella, L., Dennis, J., Tyrer, J. P., Lush, M. J., Simard, J., Easton, D. F., Antoniou, A. C., & Yang, X. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae335 · Cited by 20
Abraham, S., Foreman, N., Sidat, Z., Sandhu, P., Marrone, D., Headley, C., Akroyd, C., Nicholson, S., Brown, K., Thomas, A., et al. (2022) · British Journal of Nursing · doi:10.12968/bjon.2022.31.10.s14 · Cited by 20
Self-citationAssessing the Content Validity of Preference-Based Measures in Cancer
Gibson, A., Longworth, L., Bennett, B., Pickard, A. S., & Shaw, J. W. (2023) · Value in Health · doi:10.1016/j.jval.2023.10.006 · Cited by 24
Ethnic health inequalities in the NHS
Patel, K., & Hanif, W. (2022) · BMJ · doi:10.1136/bmj.o607 · Cited by 19
Alshahrani, A. A., Kontopantelis, E., Morgan, C., Ravindrarajah, R., Martin, G. P., & Mamas, M. A. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003419 · Cited by 21
Lam, J., Aldridge, R. W., Blackburn, R. M., & Harron, K. L. (2023) · BMC Public Health · doi:10.1186/s12889-023-16947-3 · Cited by 18
Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK population
Ficorella, L., Yang, X., Mavaddat, N., Carver, T. J., Hassan, H., Dennis, J., Tyrer, J. P., Ho, W.-K., Teo, S., Hartman, M., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03117-y · Cited by 16
Baxter, M. A., Denholm, M., Kingdon, S. J., Kathirgamakarthigeyan, S., Parikh, S. P., Shakir, R., Johnson, R., Martin, H., Walton, M., Yao, W., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02605-x · Cited by 15
Henley, P. P., Martins, T., & Zamani, R. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20247185 · Cited by 14
Darko, N., Millet, N., Usman, A., Teece, L., & Moss, E. L. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.11.030 · Cited by 13
Chen, G., Barlow, M., Down, L., Mounce, L. T. A., Merriel, S. W., Watson, J., Martins, T., & Bailey, S. E. R. (2024) · Family Practice · doi:10.1093/fampra/cmae021 · Cited by 14
Makhlouf, S., Atallah, N. M., Polotto, S., Lee, A. H. S., Green, A. R., & Rakha, E. A. (2024) · Cancers · doi:10.3390/cancers16101893 · Cited by 15
Chen, D. T.-H., Hirst, J. A., Coupland, C. A. C., Liao, W., Baldwin, D., & Hippisley‐Cox, J. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101124 · Cited by 12
Head and neck lymphedema and quality of life: the patient perspective
Starmer, H. M., Cherry, M. G., Patterson, J. M., Fleming, J. C., & Young, B. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-08150-2 · Cited by 12
Lu, J., Feng, Y., Guo, K., Sun, L., Ruan, S., & Zhang, K. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05550-z · Cited by 11
Race/ethnic inequalities in health: moving beyond confusion to focus on fundamental causes
Nazroo, J. Y. (2024) · Oxford Open Economics · doi:10.1093/ooec/odad020 · Cited by 11
REPRESENT recommendations: improving inclusion and trust in cancer early detection research
Brockhoven, F., Raphael, M., Currier, J. J., Jäderholm, C. M., Mody, P., Shannon, J., Starling, B., Turner-Uaandja, H., Pashayan, N., & Arteaga, I. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02414-8 · Cited by 13
Wanis, H. A., Møller, H., Ashkan, K., & Davies, E. (2023) · Cancers · doi:10.3390/cancers15051464 · Cited by 10
Norris, R. P., Dew, R., Greystoke, A., Cresti, N., Cain, H., Todd, A., & Sharp, L. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-0144 · Cited by 10
Lakhiani, A., Cummins, C., Kumar, S., Long, J. E., Arora, V., Balega, J., Broadhead, T., Duncan, T. J., Edmondson, R. J., Fotopoulou, C., et al. (2023) · Cancers · doi:10.3390/cancers16010075 · Cited by 11
Prostate cancer screening in Black men in Canada: a case for risk-stratified care
Otiono, K., Nkonge, B., Olaiya, O. R., & Pierre, S. A. (2022) · Canadian Medical Association Journal · doi:10.1503/cmaj.220452 · Cited by 9
Swanton, C., Bachtiar, V., Mathews, C. S., Brentnall, A. R., Lowenhoff, I., Waller, J., Bomb, M., McPhail, S., Pinches, H., Smittenaar, R., et al. (2025) · Clinical Trials · doi:10.1177/17407745241302477 · Cited by 8
NHS must tackle racism and sexism for the benefit of patients, staff, and society
Bamrah, J., Womersley, K., Nagpaul, C., Coghill, Y., Issa, R., & Hazard, L. (2025) · BMJ · doi:10.1136/bmj.r1334 · Cited by 8
Chukwusa, E., Law-Clucas, S., Gulliford, M. C., Bajwah, S., Barclay, S. I. G., Kumar, R. K., Clarke, G., Siriwimala, T., & Koffman, J. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03200-4 · Cited by 8
Risk Stratified Follow-Up for Endometrial Cancer: The Clinicians’ Perspective
Amirthanayagam, A., Boulter, L., Millet, N., McDermott, H. J., Morrison, J., Taylor, A., Miles, T., Coton, L., & Moss, E. L. (2023) · Current Oncology · doi:10.3390/curroncol30020173 · Cited by 8
Morris, M., Cook, A. D., Dodkins, J., Price, D., Waller, S., Hassan, S., Nathan, A., Aggarwal, A. K., Payne, H. A., Clarke, N. W., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078284 · Cited by 8
Zhang, S., Jin, J., Zheng, Q., & Wang, Z. (2025) · Medicine · doi:10.1097/md.0000000000041370 · Cited by 8
Slade, E., Luckham, K., Heath, A., & Owen, L. (2024) · Cancer Control · doi:10.1177/10732748241293976 · Cited by 7
Gathani, T., Dhaliwal, B., Lwiindi, J., & Dawson, S. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-091888 · Cited by 7
Deciphering gene expression patterns using large-scale transcriptomic data and its applications
Chen, S., Wang, P., Guo, H., & Zhang, Y. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae590 · Cited by 7
Ancestral diversity in complex disease genetics: from discovery to translation
Kuchenbaecker, K. B., & Navoly, G. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-025-00921-3 · Cited by 6
Zou, M., An, Y., Kuang, H., & Wang, J. (2023) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2023.104408 · Cited by 6
Metabolomic heterogeneity of ageing with ethnic diversity: a step closer to healthy ageing
Trivedi, D., Hollywood, K. A., Yun Xu, A., Wu, F. C. W., Trivedi, D. K., & Goodacre, R. (2024) · Metabolomics · doi:10.1007/s11306-024-02199-8 · Cited by 6
Smith, J., Essery, R., Yardley, L., Richardson, A., Slodkowska‐Barabasz, J., Chavlet, C., Foster, C. L., Watson, E. K., Grimmett, C., Geraghty, A. W. A., et al. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01412-2 · Cited by 6
Steventon, L., Nicum, S., Man, K. K. C., Chaichana, U., Wei, L., & Chambers, P. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.01.052 · Cited by 6
Bi, S., Zhu, J., Huang, L., Feng, W., Peng, L., Leng, L., Wang, Y., Shan, P., Kong, W., & Zhu, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136849 · Cited by 5
Jong, F. C.-D., Oyeniyi, O. S., Nnyanzi, L. A., Ling, J., Murphy, M. K., Eberhardt, J., Jarrar, R., Kabuye, J., Kalemba, M., & Robb, K. A. (2025) · BMC Public Health · doi:10.1186/s12889-025-23650-y · Cited by 5
Risk stratification in breast screening workshop
Anderson, A., Visintin, C., Antoniou, A. C., Pashayan, N., Gilbert, F. J., Hackshaw, A. K., Bhatt, R., Hill, H. R., Wright, S. J., Payne, K., et al. (2024) · BMC Proceedings · doi:10.1186/s12919-024-00306-0 · Cited by 5
Risk of subsequent primary cancers in bladder cancer survivors
Guo, Y., Zhang, Y., Mao, S., Zhang, W., Yang, F., Wang, R., Chen, H., Zhang, A.-H., & Yao, X. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01502-0 · Cited by 5
Jong, F. C.-D., Eberhardt, J., Ling, J., Kotzur, M., Oyeniyi, O. S., Nnyanzi, L. A., Kabuye, J., Kalemba, M., & Robb, K. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315288 · Cited by 5
Feng, Q., Izzi‐Engbeaya, C. N., Beaney, T. E., Smith, A., Manousou, P., & Woodward, M. (2025) · BMC Medicine · doi:10.1186/s12916-025-04288-4 · Cited by 6
Martins, T., Ukoumunne, O. C., Lyratzopoulos, G., Hamilton, W. T., & Abel, G. (2023) · Cancers · doi:10.3390/cancers15123100 · Cited by 4
Invisible spectrum: a model for minority community public engagement in cancer research
O’Grady, S., Ralston, J. C., McKiernan, E., Lanigan, F. T., Salauddin, M., Sharmin, S., McVeigh, T. P., Gallagher, W. M., Guerin, S., Rahman, A., et al. (2025) · Research Involvement and Engagement · doi:10.1186/s40900-025-00726-y · Cited by 4
Ethnicity and breast cancer incidence in over 329 500 women in England in 2011–2019
Gathani, T., Kan, S. W., Sweetland, S., & REEVES, G. K. (2025) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2025.109585 · Cited by 4
Mandic, M., Safizadeh, F., Schöttker, B., Hoffmeister, M., & Brenner, H. (2025) · BMC Medicine · doi:10.1186/s12916-025-04052-8 · Cited by 3
Jong, F. C.-D., Eberhardt, J., Oyeniyi, O. S., Ratcliffe, E., Kabuye, J., Kalemba, M., Nnyanzi, L. A., Murphy, M. K., & Robb, K. A. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-105803 · Cited by 3
Wu, Q., Li, Q., & Qin, Y. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103709 · Cited by 3
Martins, T., Down, L., Samuels, A., Lavu, D., Hamilton, W. T., Abel, G., & Neal, R. D. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2024.0518 · Cited by 3
Birch, R. J., Burr, N. E., Taylor, J., Downing, A., Quirke, P., Morris, E. J. A., Turvill, J. L., & Thoufeeq, M. (2025) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2024-001629 · Cited by 3
Nnate, D. A., & Ball, J. (2022) · Cancer · doi:10.1002/cncr.34337 · Cited by 3
Ciltacabtagene Autoleucel (Carvykti)
CADTH (2023) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2023.706 · Cited by 3
Effect of Genetic Ancestry on Phenotypes and Genotypes in Papillary Thyroid Cancer
Chi, S., Hsu, Y., & Cheng, S. (2025) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2024.0189 · Cited by 2
Butterworth, V., Young, T., Drake, H., Palmer, I., Avgoulea, T., Ivy, E., Andriolo, J., Creppy, C., Routledge, C., Adjogatse, D., et al. (2025) · ESMO Real World Data and Digital Oncology · doi:10.1016/j.esmorw.2025.100162 · Cited by 2
Kagenaar, E., Lugo-Palacios, D. G., Aggarwal, A. K., Hutchings, A., Han, L., O’Neill, S., Rachet, B., Edwards, J. G., Finn, C. F., & Grieve, R. (2025) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2025.100662 · Cited by 2
Chaplin, A., Archangelidi, O., Hagberg, K. W., Neasham, D., & Kafatos, G. (2025) · Clinical Epidemiology · doi:10.2147/clep.s558429 · Cited by 2
Martins, T., Lavu, D., Hamilton, W., Abel, G., & Neal, R. D. (2026) · Scientific Reports · doi:10.1038/s41598-026-36070-8 · Cited by 2
Management of Malignant Pleural Effusions in U.S. Veterans: A Retrospective Review
Mohs, Z., DeVillers, M., Ziegler, S., Basson, M. D., & Newman, W. (2022) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.oa.22-00124 · Cited by 2
Mandane, B., Amirthanayagam, A., Patel, N., Darko, N., & Moss, E. L. (2023) · Trials · doi:10.1186/s13063-023-07572-x · Cited by 2
Improving Inclusivity, Equity, and Diversity in Oncology Clinical Trials: A European Perspective
Langley, B., Talas, S., El-Shakankery, K. H., & Michie, C. O. (2023) · EMJ Oncology · doi:10.33590/emjoncol/10303428 · Cited by 2
Talbot, A., Jebb, S. A., Foster, C. L., Realpe, A. X., Wheatstone, P., Buczacki, S. J. A., & Koutoukidis, D. A. (2024) · BMC Cancer · doi:10.1186/s12885-024-12464-7 · Cited by 2
Wang, J., Apizi, A., Tao, N., & An, H. (2024) · PeerJ · doi:10.7717/peerj.17827 · Cited by 2
Inclusivity in prostate cancer and exercise research: a systematic review
Ashton, R. E. M., Faghy, M. A., Roscoe, C. M. P., & Aning, J. J. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08793-9 · Cited by 2
Puhr, H. C., Winkler, E. C., & Preusser, M. (2025) · ESMO Open · doi:10.1016/j.esmoop.2024.104093 · Cited by 2
Breast cancer: an update for community nurses
Nazarko, L. (2025) · Independent Nurse · doi:10.12968/indn.2025.1.14 · Cited by 2
Equity in cancer genomics in the UK: a cross-sectional analysis of a national cancer cohort
Nguyen, T., Tallman, S., Cho, Y., Sosinsky, A., Ambrose, J. C., Thorn, S., Mackintosh, M. E., Brown, M. A., Moutsianas, L., Silver, M. J., et al. (2025) · The Lancet Oncology · doi:10.1016/s1470-2045(25)00199-8 · Cited by 2
Dodd, C. A., Lond, B. J., Davey, Z., Williamson, I. R., Darlison, L., Hall, S., McPhelim, J., Rawlinson, J., & Henshall, C. L. (2025) · Journal of Advanced Nursing · doi:10.1111/jan.70134 · Cited by 2
Chartkul, M., Cook, F., & Govender, R. (2024) · Oral Oncology Reports · doi:10.1016/j.oor.2024.100229 · Cited by 2
Willis, S., Aparicio, P. F., Steel, R., & Leblay, G. (2022) · Archives of Clinical and Biomedical Research · doi:10.26502/acbr.50170298 · Cited by 1
Tsang, C., Arnold, K. F., Duffield, C., Oikonomou, S., Price, T., Mehdikhanova, T., Wood, S., & Garg, M. K. (2025) · eJHaem · doi:10.1002/jha2.70064 · Cited by 1
Common Risk Factors in Gastrointestinal Cancers: A Narrative Review
Akhondi, H., Kalteh, E. A., & Lotfi, M. H. (2025) · Medical Principles and Practice · doi:10.1159/000547241 · Cited by 1
Disparity in Cancer Screening Among Black and Other Ethnic Minority Groups in the UK
Iyizoba-Ebozue, Z., Njoku, K., Fatimilehin, A., Mbanu, P., & Adeleke, S. M. (2025) · Clinical Oncology · doi:10.1016/j.clon.2025.103992 · Cited by 1
Indhumathi, R., Dar, S. A., Rather, A. A., Osman, A. A. F., Ruhela, S., Yasika, G., & Mozhiselvi, S. A. (2026) · International Journal of Statistics in Medical Research · doi:10.6000/1929-6029.2026.15.13 · Cited by 1
Watson, L., Sharp, L., Hamilton, D. W., Thornton, V., & Patterson, J. M. (2026) · International Journal of Language & Communication Disorders · doi:10.1111/1460-6984.70275 · Cited by 1
Otiono, K., Nkonge, B., Olaiya, O. R., & Pierre, S. A. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.220452-f · Cited by 1
Daun dan Biji Srikaya (Annona squamosa L.) dan Potensinya sebagai Antikanker
Fadholly, A. (2023) · Jurnal Veteriner dan Biomedis · doi:10.29244/jvetbiomed.1.1.45-50 · Cited by 1
Law, K., McCabe, M. G., van der Veer, S. N., & Yorke, J. (2024) · Neuro-Oncology Practice · doi:10.1093/nop/npad082 · Cited by 1
Artificial Intelligence in Cutaneous Lesions: Where do we Stand and What is Next?
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4911-7 · Cited by 1
Lam, J., Aldridge, R. W., Blackburn, R. M., & Harron, K. L. (2023) · Research Square · doi:10.21203/rs.3.rs-3178290/v1 · Cited by 1
Ramsay, D. A., & Bunn, S. (2023) · doi:10.58248/pb56 · Cited by 3
Disparities in cancer genomics by ancestry in the 100,000 Genomes ProjectPreprint
Nguyen, T., Tallman, S., Cho, Y., Sosinsky, A., Ambrose, J. C., Thorn, S., Mackintosh, M. E., Brown, M. A., Moutsianas, L., Silver, M. J., et al. (2024) · medRxiv · doi:10.1101/2024.11.14.24317310 · Cited by 1
Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK populationPreprint
Ficorella, L., Yang, X., Mavaddat, N., Carver, T. J., Hassan, H., Dennis, J., Tyrer, J. P., Ho, W.-K., Teo, S., Hartman, M., et al. (2025) · medRxiv · doi:10.1101/2025.02.14.25322307 · Cited by 1
Seviiri, M. (2022) · Queensland University of Technology · doi:10.5204/thesis.eprints.236969
Allen, I., Hassan, H., Fru, Y. J. W., Huntley, C., Loong, L., Rahman, T., Torr, B., Bacon, A., Knott, C. S., José, S., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4691775
Self-citationEpidemiology of Bladder Cancer: Current Insight
Головко, С. В. (2024) · Health of Man · doi:10.30841/2786-7323.1.2024.303832
Sajjad, P. F., Shepperd, S., Dawson, S., Dhaliwal, B., Roberts, N. W., & Gathani, T. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-092480
Harrison, J., Sullivan, F., Keenan, K. L., & Kulu, H. (2024) · BMC Public Health · doi:10.1186/s12889-024-20813-1
GHPFL: Advancing Personalized Edge-Based Learning Through Optimized Bandwidth Utilization
Mo, K., Lin, W., Lu, J., Xue, C. J., Shao, Y., & Xu, H. L. (2025) · IEEE Transactions on Cloud Computing · doi:10.1109/tcc.2025.3540023 · Cited by 1
Feng, Q., Izzi‐Engbeaya, C. N., Manousou, P., & Woodward, M. (2025) · medRxiv · doi:10.1101/2025.03.06.25323330
Liu, X., Hao, J., Yuan, Y., & Fang, L. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04295-5
Adomah, S., & Cruickshank, S. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01691-1
Metadata
- Authors
- Delon, C., Brown, K. F., Payne, N. W. S., Kotrotsios, Y., Vernon, S., & Shelton, J.
- Affiliations
- Cancer Research UK (GB)
- NHS Digital (GB)
- Corresponding author
- Delon, Christine
- Venue
- British Journal of Cancer
- Published
- 2022-03-02
- Volume
- 126
- Issue
- 12
- Pages
- 1765-1773
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC9174248
- OpenAlex
- W4214903413
- Cited by
- 137
- References
- 54
- Citations by year
- 2026: 22 · 2025: 43 · 2024: 40 · 2023: 24 · 2022: 8
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- British Journal of Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Health › Health disparities and outcomes
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- cancer incidence, ethnic disparities, ethnic minorities, Asian ethnicity, Black ethnicity, melanoma, tobacco-related cancer, prostate cancer, multiple myeloma, Hodgkin's disease, thyroid cancer, gastrointestinal cancer, lung cancer, bladder cancer, esophageal cancer, England
- MeSH terms
- Ethnicity, Gastrointestinal Neoplasms, Humans, Male, Minority Groups, Risk Factors, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review